Matthew Oberley
Chief Clinical Officer Caris Life Sciences
Seminars
Thursday 5th February 2026
Caris Assure: Advancing Clinical & Biopharma Insight Through Liquid Biopsy
9:00 am
- Expanding WES-based reporting to incorporate pharmacogenomic and emerging biomarkers (e.g., DPYD)
- CHIP-aware liquid biopsy interpretation to reduce false positives and strengthen variant confidence
- Real-world case studies
